Vilazodone

Antidepressants: Current Strategies and Future Opportunities

(2011) Archana Uppal et al.   CURRENT PHARMACEUTICAL DESIGN

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

(2011) Arif Khan et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Future of Psychopharmacology of Depression

(2010) Trina Chang et al.   JOURNAL OF CLINICAL PSYCHIATRY

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

(2009) Arif Khan   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder

(2009) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHIATRY

Blues from the Neighborhood? Neighborhood Characteristics and Depression

(2008) D. Kim   EPIDEMIOLOGIC REVIEWS

Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors

(2008) C. Moret et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review

(2008) R. Whale et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

(2008) Mark J. Millan   Neurotherapeutics

Depression in the medically Ill: Diagnostic and therapeutic implications

(2008) Meera Narasimhan et al.   Current Psychiatry Reports